Clinical Trials Logo

Achilles Tendinitis clinical trials

View clinical trials related to Achilles Tendinitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT03300531 Not yet recruiting - Rotator Cuff Tear Clinical Trials

Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease

Start date: December 1, 2017
Phase: Phase 2
Study type: Interventional

This is a randomized parallel controlled double-blind phase 2 clinical study.All subjects are recruited from the patients of rotator cuff tear, lateral epicondylitis or chronic achilles tendonitis. Patients will be randomly divided into three groups. Autologous pure platlet-rich plasma (P-PRP) and platlet-rich plasma (PRP) are purified from the peripheral blood .Patients of case groups will receive P-PRP or PRP injection once a week for three times while the control group received the same dose compound betamethasone injection. Follow up visit will occur at 1 month,3 months, 6 months,12 months after the last injection. Clinical quantitative assessment will measure by the visual analogue scale(VAS). The secondary outcomes are the constant-murley score(CMS) and the rating scale of the American shoulder and elbow surgeons(ASES) and the disability of arm shoulder and hand(DASH). The objective evaluation methods is that the examination of MRI or ultrasound were accomplished before the first injection and at 6 and 12 months afterwards.

NCT ID: NCT02757664 Completed - Tendinopathy Clinical Trials

Clinical Trial to Evaluate the Adjuvant Effect of Shock Wave Therapy in the Insertional Achilles Tendinopathy

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Background: There is no consensus regarding the treatment of insertional tendinopathies. The good results of the eccentric training in the management of the non-insertional Achilles tendinopathy were not reproducible in the insertional disease. Shock wave therapy is described as an alternative to these patients. Hypothesis: The shock wave therapy allied to the eccentric strengthening protocol presents better results that the eccentric strengthening associated to placebo. Design: Double blinded (outcome assessor and patient) randomized clinical trial, with the use of placebo, in parallel groups. Materials and Methods: Nine-three patients with chronic insertional tendinopathy will be enrolled in a randomized trial. Participants will be divided in two groups, one containing the combination of shock wave and eccentric exercises as treatment and the other comprehending the exercises assembled to placebo. The assessment of outcomes will occur in 2, 4, 6, 12 and 24 weeks of the beginning of the study. Patients will be evaluated for pain, activity and function by the VISA-A (the Victorian Institute of Sport Assessment-Achilles [VISA-A] questionnaire).

NCT ID: NCT02646579 Completed - Clinical trials for Patellofemoral Pain Syndrome

Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only

Start date: October 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if dry needling both low back and extremity areas is more effective for reducing pain and improving strength, balance and functional performance among patients with chronic musculoskeletal conditions compared to dry needling of extremity areas only.

NCT ID: NCT02064062 Recruiting - Tendinopathy Clinical Trials

Autologous Stem Cells in Achilles Tendinopathy

Start date: January 2015
Phase: Phase 2
Study type: Interventional

This study is looking at a new treatment, using the patient's own stem cells (the repair cells of the body), to see whether this can help reduce pain and promote healing of the Achilles tendon, without side effects.

NCT ID: NCT01911650 Completed - Achilles Tendinitis Clinical Trials

A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy

Start date: June 2013
Phase: N/A
Study type: Interventional

The overall goal of this proposal is to correlate ultrasound elastography technique with more standard clinically based outcome measures within the setting of a small sample sized group of patients affected by moderate-to- severe, chronic (>6months) midsubstance Achilles tendinopathy (AT).